These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 835882)

  • 1. Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
    Farney RJ; Morris AH; Armstrong JD; Hammer S
    Am Rev Respir Dis; 1977 Jan; 115(1):135-45. PubMed ID: 835882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal renal malformation following treatment of Hodgkin's disease during pregnancy.
    Mennuti MT; Shepard TH; Mellman WJ
    Obstet Gynecol; 1975 Aug; 46(2):194-6. PubMed ID: 1153150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pneumonitis associated with MOPP chemotherapy of Hodgkin's disease.
    Cersosimo RJ; Licciardello JT; Matthews SJ; Bromer R; Hong WK
    Drug Intell Clin Pharm; 1984; 18(7-8):609-11. PubMed ID: 6101251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
    Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
    J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of Hodgkin's disease].
    Amiel JL; Mathé G
    Rev Prat; 1974 Oct; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple-drug therapy in Hodgkin's disease.
    Rubens RD; Wiltshaw E; Boesen E; Galton DA
    Eur J Cancer (1965); 1972 Oct; 8(5):477-84. PubMed ID: 4651783
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.
    Brandriff BF; Meistrich ML; Gordon LA; Carrano AV; Liang JC
    Hum Genet; 1994 Mar; 93(3):295-9. PubMed ID: 8125481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
    Luce JK; Frei E; Gehan EA; Coltman CA; Talley R; Monto RW
    Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037
    [No Abstract]   [Full Text] [Related]  

  • 12. [10 years of DeVita protocol].
    Gassmann W; Schmitz N; Löffler H
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1043-4. PubMed ID: 6896303
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary treatment of disseminated Hodgkin's disease with BCNU alone and in combination with vincristine, procarbazine, and prednisone.
    Harrison DT; Neiman PE
    Cancer Treat Rep; 1977 Aug; 61(5):789-95. PubMed ID: 329978
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
    Mantovani G; Del Giacco GS; Marongiu F; Tognella S; Carassi UE
    Acta Haematol; 1982; 67(4):287-8. PubMed ID: 6810628
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary toxicity following MOPP chemotherapy.
    Millward MJ; Cohney SJ; Byrne MJ; Ryan GF
    Aust N Z J Med; 1990 Jun; 20(3):245-8. PubMed ID: 2196871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
    Neretto G; Giovanelli E; Agricola R; Furno F
    Minerva Med; 1978 Oct; 69(49):3367-71. PubMed ID: 724146
    [No Abstract]   [Full Text] [Related]  

  • 17. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Andrieu JM; Colonna P
    J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E
    Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy (MOPP) in the management of advanced Hodgkin's disease. A progress report on 55 patients.
    Cooper IA; Rana C; Madigan JP; Motteram R; Maritz JS; Turner CN
    Med J Aust; 1972 Jan; 1(2):41-9. PubMed ID: 5025152
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
    Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
    NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.